- Home
- MREO vs KTF Comparison
MREO vs KTF Comparison
Compare MREO & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- KTF
- Stock Information
- Founded
- MREO 2015
- KTF 1988
- Country
- MREO United Kingdom
- KTF United States
- Employees
- MREO N/A
- KTF N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- KTF Finance Companies
- Sector
- MREO Health Care
- KTF Finance
- Exchange
- MREO Nasdaq
- KTF Nasdaq
- Market Cap
- MREO 311.8M
- KTF 337.7M
- IPO Year
- MREO N/A
- KTF N/A
- Fundamental
- Price
- MREO $1.84
- KTF $9.26
- Analyst Decision
- MREO Strong Buy
- KTF
- Analyst Count
- MREO 5
- KTF 0
- Target Price
- MREO $7.40
- KTF N/A
- AVG Volume (30 Days)
- MREO 1.6M
- KTF 103.3K
- Earning Date
- MREO 11-10-2025
- KTF 01-01-0001
- Dividend Yield
- MREO N/A
- KTF 3.54%
- EPS Growth
- MREO N/A
- KTF N/A
- EPS
- MREO N/A
- KTF 0.39
- Revenue
- MREO $500,000.00
- KTF N/A
- Revenue This Year
- MREO N/A
- KTF N/A
- Revenue Next Year
- MREO $72.16
- KTF N/A
- P/E Ratio
- MREO N/A
- KTF $23.10
- Revenue Growth
- MREO N/A
- KTF N/A
- 52 Week Low
- MREO $1.47
- KTF $7.40
- 52 Week High
- MREO $4.29
- KTF $9.12
- Technical
- Relative Strength Index (RSI)
- MREO 45.03
- KTF 60.07
- Support Level
- MREO $1.65
- KTF $9.14
- Resistance Level
- MREO $1.93
- KTF $9.28
- Average True Range (ATR)
- MREO 0.12
- KTF 0.05
- MACD
- MREO -0.02
- KTF -0.00
- Stochastic Oscillator
- MREO 36.00
- KTF 86.67
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.